An update on the diagnosis and treatment of Parkinson disease

P Rizek, N Kumar, MS Jog - Cmaj, 2016 - cmaj.ca
Methods We used Canadian and American national guidelines to inform this review, in
addition to published systematic reviews that were known to us. We identified additional …

Sex differences in movement disorders

S Meoni, A Macerollo, E Moro - Nature Reviews Neurology, 2020 - nature.com
In a range of neurological conditions, including movement disorders, sex-related differences
are emerging not only in brain anatomy and function, but also in pathogenesis, clinical …

Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): scale presentation and clinimetric testing results

CG Goetz, BC Tilley, SR Shaftman… - … : official journal of the …, 2008 - Wiley Online Library
We present a clinimetric assessment of the Movement Disorder Society (MDS)‐sponsored
revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS). The MDS‐UDPRS …

The relevance of gender in Parkinson's disease: a review

M Picillo, A Nicoletti, V Fetoni, B Garavaglia… - Journal of …, 2017 - Springer
Since the official and systematic inclusion of sex and gender in biomedical research, gender
differences have been acknowledged as important determinants of both the susceptibility to …

Parkinson's disease in the Western Pacific Region

SY Lim, AH Tan, A Ahmad-Annuar, C Klein… - The Lancet …, 2019 - thelancet.com
Summary 1· 8 billion people of diverse ethnicities and cultures live in the Western Pacific
Region. The increasing longevity of populations in this region is a major contributor to the …

[PDF][PDF] European physiotherapy guideline for Parkinson's disease

S Keus, M Munneke, M Graziano… - The Netherlands …, 2014 - parkinsonnet.nl
6 Guidelines((“guideline”[pt] OR “practice guideline”[pt] OR “health planning guidelines”[mh]
OR “consensus development conference”[pt] OR “consensus development conference …

Missing pieces in the Parkinson's disease puzzle

JA Obeso, MC Rodriguez-Oroz, CG Goetz, C Marin… - Nature medicine, 2010 - nature.com
Parkinson's disease is a neurodegenerative process characterized by numerous motor and
nonmotor clinical manifestations for which effective, mechanism-based treatments remain …

Progression of Parkinson's disease in the clinical phase: potential markers

W Maetzler, I Liepelt, D Berg - The Lancet Neurology, 2009 - thelancet.com
Neuromodulatory or even neuroprotective therapy could soon be available for Parkinson's
disease (PD), raising the question of how we should define and measure disease …

Management of dysphagia in patients with Parkinson's disease and related disorders

G Umemoto, H Furuya - Internal Medicine, 2020 - jstage.jst.go.jp
Various methods of rehabilitation for dysphagia have been suggested through the
experience of treating stroke patients. Although most of these patients recover their …

Cardiac abnormalities in Parkinson's disease and Parkinsonism

FA Scorza, AC Fiorini, CA Scorza, J Finsterer - Journal of Clinical …, 2018 - Elsevier
Objectives Though there is increasing evidence for primary cardiac disease in Parkinson's
disease (PD) and Parkinsonism (PS), this evidence is hardly included in the general …